Correlation Between InMed Pharmaceuticals and Metacrine
Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Metacrine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Metacrine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMed Pharmaceuticals and Metacrine, you can compare the effects of market volatilities on InMed Pharmaceuticals and Metacrine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Metacrine. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Metacrine.
Diversification Opportunities for InMed Pharmaceuticals and Metacrine
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between InMed and Metacrine is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Metacrine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metacrine and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Metacrine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metacrine has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Metacrine go up and down completely randomly.
Pair Corralation between InMed Pharmaceuticals and Metacrine
Considering the 90-day investment horizon InMed Pharmaceuticals is expected to under-perform the Metacrine. In addition to that, InMed Pharmaceuticals is 2.6 times more volatile than Metacrine. It trades about 0.0 of its total potential returns per unit of risk. Metacrine is currently generating about 0.14 per unit of volatility. If you would invest 39.00 in Metacrine on September 2, 2024 and sell it today you would earn a total of 10.00 from holding Metacrine or generate 25.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.47% |
| Values | Daily Returns |
InMed Pharmaceuticals vs. Metacrine
Performance |
| Timeline |
| InMed Pharmaceuticals |
| Metacrine |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
InMed Pharmaceuticals and Metacrine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with InMed Pharmaceuticals and Metacrine
The main advantage of trading using opposite InMed Pharmaceuticals and Metacrine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Metacrine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metacrine will offset losses from the drop in Metacrine's long position.| InMed Pharmaceuticals vs. Tff Pharmaceuticals | InMed Pharmaceuticals vs. Eliem Therapeutics | InMed Pharmaceuticals vs. Inhibrx | InMed Pharmaceuticals vs. Enliven Therapeutics |
| Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |